Stocks and securities in focus
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vitrolife AB | 10.050% | 10.638% | 10.470% | 75.563% | 23.112% | - | - |
| Novavax Inc. | 9.340% | 4.538% | -1.008% | 46.276% | 150.750% | -94.343% | 99.857% |
| Ironwood Pharmaceuticals | 6.540% | 5.069% | -29.302% | -45.389% | -55.294% | -59.286% | -44.854% |
| Sangamo Therapeutics Inc. | 5.100% | -0.131% | 15.854% | -12.159% | 32.655% | -90.885% | -92.310% |
| CEL-SCI Corp. | 4.750% | -2.338% | -13.979% | -24.500% | -61.957% | -89.378% | -85.511% |
| Immutep LTD ADR | 4.500% | 9.174% | 19.000% | 38.372% | 9.174% | -24.204% | 84.525% |
| Enlivex Therapeutics Ltd. | 3.740% | 2.778% | -7.500% | -49.545% | -50.446% | -88.900% | -95.249% |
| Puma Biotechnology Inc. | 3.270% | -2.118% | -37.060% | -33.988% | -43.201% | -65.634% | -76.653% |
| ImmunityBio Inc. | 3.110% | -5.892% | -26.680% | 136.954% | -24.195% | -62.949% | 225.569% |
| Cytomx Therapeutics Inc | 3.070% | -1.300% | -16.431% | -21.838% | -23.854% | -75.291% | -86.592% |
| Viking Therapeutics Inc | 2.370% | 0.485% | 10.683% | 363.604% | 231.827% | 946.159% | 815.575% |
| Eli Lilly Corp. | 2.200% | 2.010% | 18.763% | 72.869% | 64.356% | 290.373% | 744.492% |
| Vivoryon Therapeutics N.V. | 1.410% | -3.378% | -12.449% | -82.922% | -73.321% | -89.381% | -66.537% |
| Esperion Therapeutis.Inc. | 1.360% | 4.692% | -22.923% | 13.082% | -42.474% | -84.881% | -95.050% |
| Viatris Inc. | 1.260% | 4.188% | -2.494% | 8.711% | 12.233% | -10.404% | -38.199% |
| Iovance Biotherapeutics Inc. | 1.020% | -0.518% | 27.568% | 87.878% | 35.182% | -47.013% | -44.447% |
| Indivior plc | 0.890% | 2.727% | -7.377% | -45.933% | -18.234% | 0.983% | 249.521% |
| Bayer AG | 0.800% | -0.090% | 1.105% | -44.730% | -17.103% | -40.950% | -58.680% |
| Evotec SE | 0.680% | 13.981% | -22.358% | -68.893% | -68.703% | -84.296% | -66.692% |
| Fibrogen Inc. | 0.630% | -7.928% | -65.172% | -52.386% | -60.556% | -96.558% | -99.191% |
| AbbVie Inc. | 0.560% | 0.612% | 2.814% | 30.766% | 26.752% | 73.791% | 195.967% |
| Nektar Therapeutics | 0.430% | 6.359% | -7.827% | 110.047% | 131.680% | -91.009% | -92.785% |
| Thermo Fisher Scientific Inc. | 0.400% | 2.752% | -2.215% | 8.652% | 15.415% | 17.512% | 113.183% |
| G1 Therapeutics | 0.080% | 0.235% | 73.954% | 314.563% | 132.909% | -48.554% | - |
| Acadia Pharmaceuticals | -0.210% | -0.703% | -17.973% | -43.500% | -50.264% | -1.807% | -43.658% |
| Sanofi S.A. | -0.220% | 1.354% | 6.430% | 2.518% | 13.426% | 15.603% | 30.262% |
| Cardiff Oncology Inc. | -0.240% | -0.477% | -2.113% | 26.517% | 58.435% | -66.905% | 21.887% |
| UnitedHealth Group Inc. | -0.390% | 2.182% | 0.094% | 18.491% | 12.025% | 50.557% | 150.964% |
| Agios Pharmaceuticals Inc. | -0.490% | 0.971% | -4.147% | 67.742% | 101.942% | 11.528% | 20.458% |
| Novocure Ltd | -0.620% | 10.773% | -17.407% | -11.155% | 24.974% | -84.358% | -78.485% |